West Therapeutics, Inc   Report issue

For profit Phase 3
Founded: Northbrook IL United States (2017)

Organization Overview

First Clinical Trial
2018
NCT03347526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

West Therapuetics, Inc

Active Ingredients

Drugs in Phase 3 Trials (2)

tetracosactide (1 trial)

vigabatrin (sabril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Spasm (Phase 3)

Spasms, Infantile (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2